{"transactions":[{"id":750079,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:14:34.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":false,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":89312},"source":{"system":"sec-edgar","filing":"0001062822-26-000108","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000108/form4.xml","form_type":"4"}},{"id":750078,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-04T20:14:34.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":true,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":174486,"source":{"system":"sec-edgar","filing":"0001062822-26-000108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000108/form4.xml","form_type":"4"}},{"id":794405,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T20:27:49.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":43478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":43478,"derivative":{"exercise_price":1.61,"expiration_date":"2036-05-01","underlying":"Common Stock","underlying_shares":43478},"source":{"system":"sec-edgar","filing":"0001062822-26-000080","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000080/form4.xml","form_type":"4"}},{"id":794404,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-05-04T20:27:49.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":35714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":35714,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":35714},"source":{"system":"sec-edgar","filing":"0001062822-26-000080","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000080/form4.xml","form_type":"4"}},{"id":1125940,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-06-03T20:25:29.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":89312,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":89312},"source":{"system":"sec-edgar","filing":"0001127602-25-016480","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225016480/form4.xml","form_type":"4"}},{"id":1125939,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-03T20:25:29.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":103806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":103806,"derivative":{"exercise_price":0.6216,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":103806},"source":{"system":"sec-edgar","filing":"0001127602-25-016480","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225016480/form4.xml","form_type":"4"}},{"id":1151242,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-13T21:52:13.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":36810},"source":{"system":"sec-edgar","filing":"0001127602-25-014146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225014146/form4.xml","form_type":"4"}},{"id":1151241,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-13T21:52:13.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":85174,"source":{"system":"sec-edgar","filing":"0001127602-25-014146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225014146/form4.xml","form_type":"4"}},{"id":1519512,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-13T20:05:26.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":36810,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":36810},"source":{"system":"sec-edgar","filing":"0001127602-24-015084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224015084/form4.xml","form_type":"4"}},{"id":1519511,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:05:26.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":44906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":44906,"derivative":{"exercise_price":1.79,"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":44906},"source":{"system":"sec-edgar","filing":"0001127602-24-015084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224015084/form4.xml","form_type":"4"}},{"id":1534035,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-04-29T20:21:37.000Z","date":"2024-04-28","kind":"exercise","planned":false,"acquired":false,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-24-013558","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224013558/form4.xml","form_type":"4"}},{"id":1534034,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-29T20:21:37.000Z","date":"2024-04-28","kind":"exercise","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48364,"source":{"system":"sec-edgar","filing":"0001127602-24-013558","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224013558/form4.xml","form_type":"4"}},{"id":1851925,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:00:24.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":29.02,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0000899243-23-015756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1413573/000089924323015756/doc4.xml","form_type":"4"}},{"id":1851924,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:00:24.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":6.7,"expiration_date":"2031-02-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-23-015756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1413573/000089924323015756/doc4.xml","form_type":"4"}},{"id":1851923,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:00:24.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2071,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-015756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413573/000089924323015756/doc4.xml","form_type":"4"}},{"id":1883126,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-22T20:07:28.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":false,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-23-016439","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016439/form4.xml","form_type":"4"}},{"id":1883125,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-22T20:07:28.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40332,"source":{"system":"sec-edgar","filing":"0001127602-23-016439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016439/form4.xml","form_type":"4"}},{"id":1884400,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T21:45:41.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":2071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units (\"RSUs\") granted under the Issuer's 2021 Incentive Award Plan (the \"2021 Plan\").  Each RSU entitles the Reporting Person to receive one share of Issuer common stock upon vesting.  The RSUs shall vest in full upon the earlier to occur of (i) the first anniversary of the date of grant, (ii) the Issuer's next occurring annual meeting of stockholders, or (iii) a Change of Control (as defined in the 2021 Plan), subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":2071,"source":{"system":"sec-edgar","filing":"0001209191-23-031191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413573/000120919123031191/doc4.xml","form_type":"4"}},{"id":1911585,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-28T20:30:07.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":12658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":12658,"derivative":{"exercise_price":2.36,"expiration_date":"2033-04-28","underlying":"Common Stock","underlying_shares":12658},"source":{"system":"sec-edgar","filing":"0001127602-23-013789","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013789/form4.xml","form_type":"4"}},{"id":1911584,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-28T20:30:07.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":8032,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-23-013789","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013789/form4.xml","form_type":"4"}},{"id":2260536,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-23T20:18:30.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":9302,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-22-015379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015379/form4.xml","form_type":"4"}},{"id":2260535,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T20:18:30.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":14402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":14402,"derivative":{"exercise_price":1.77,"expiration_date":"2032-05-21","underlying":"Common Stock","underlying_shares":14402},"source":{"system":"sec-edgar","filing":"0001127602-22-015379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015379/form4.xml","form_type":"4"}},{"id":2261662,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-20T23:28:25.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full upon the earlier to occur of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":20500,"derivative":{"exercise_price":29.02,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001209191-22-031177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413573/000120919122031177/doc4.xml","form_type":"4"}},{"id":2286826,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-02T20:22:51.000Z","date":"2022-04-30","kind":"exercise","acquired":false,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-22-012835","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012835/form4.xml","form_type":"4"}},{"id":2286825,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-02T20:22:51.000Z","date":"2022-04-30","kind":"exercise","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31030,"source":{"system":"sec-edgar","filing":"0001127602-22-012835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012835/form4.xml","form_type":"4"}},{"id":2733367,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-03T21:06:55.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":6475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6475,"derivative":{"exercise_price":5.04,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":6475},"source":{"system":"sec-edgar","filing":"0001127602-21-014971","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014971/form4.xml","form_type":"4"}},{"id":2733366,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-05-03T21:06:55.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":4024,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-21-014971","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014971/form4.xml","form_type":"4"}},{"id":2738798,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-04-27T20:51:35.000Z","date":"2021-04-24","kind":"exercise","acquired":false,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-21-014524","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014524/form4.xml","form_type":"4"}},{"id":2738797,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-27T20:51:35.000Z","date":"2021-04-24","kind":"exercise","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27006,"source":{"system":"sec-edgar","filing":"0001127602-21-014524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014524/form4.xml","form_type":"4"}},{"id":3169370,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:49:41.000Z","date":"2020-04-26","kind":"exercise","acquired":false,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-20-014572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014572/form4.xml","form_type":"4"}},{"id":3169369,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:49:41.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":10638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-20-014572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014572/form4.xml","form_type":"4"}},{"id":3169368,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T20:49:41.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":18115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":18115,"derivative":{"exercise_price":1.86,"expiration_date":"2030-04-24","underlying":"Common Stock","underlying_shares":18115},"source":{"system":"sec-edgar","filing":"0001127602-20-014572","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014572/form4.xml","form_type":"4"}},{"id":3169367,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-27T20:49:41.000Z","date":"2020-04-26","kind":"exercise","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16368,"source":{"system":"sec-edgar","filing":"0001127602-20-014572","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014572/form4.xml","form_type":"4"}},{"id":3546815,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-04-29T21:03:41.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":3466,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-19-016492","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219016492/form4.xml","form_type":"4"}},{"id":3546814,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-29T21:03:41.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":6519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6519,"derivative":{"exercise_price":5.67,"expiration_date":"2029-04-26","underlying":"Common Stock","underlying_shares":6519},"source":{"system":"sec-edgar","filing":"0001127602-19-016492","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219016492/form4.xml","form_type":"4"}},{"id":3955209,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-27T21:42:04.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant."}],"balance_after":2857,"derivative":{"exercise_price":7.8,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":2857},"source":{"system":"sec-edgar","filing":"0001127602-18-015457","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218015457/form4.xml","form_type":"4"}},{"id":3955208,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-27T21:42:04.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12902,"source":{"system":"sec-edgar","filing":"0001127602-18-015457","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218015457/form4.xml","form_type":"4"}},{"id":4340763,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-01T20:54:36.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":2857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant."}],"balance_after":2857,"derivative":{"exercise_price":15.61,"expiration_date":"2027-04-28","underlying":"Common Stock","underlying_shares":2857},"source":{"system":"sec-edgar","filing":"0001127602-17-016072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217016072/form4.xml","form_type":"4"}},{"id":4340762,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41455,"kind":"person","name":"Swain Judith L","position":1,"cik":"0001413573","reported_name":"Swain Judith L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-01T20:54:36.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":1281,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10338,"source":{"system":"sec-edgar","filing":"0001127602-17-016072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217016072/form4.xml","form_type":"4"}}]}